“…[40][41][42][43][44][45] In addition, several studies showed an association of upper respiratory tract infections and/or AOM with aberrant MBL levels and/or genotypes, 11,46-48 but this was not confirmed by others. 49,50 These conflicting results might be caused by variation in age of subjects under study, because in one prospective study in children from Greenland, the maximal effect of MBL deficiency was observed in children between 6 and 17 months of age, whereas the effect could not be demonstrated in younger or older children. 11 The fact that we find MBL relevance only below the age of 24 months makes sense, because adaptive immunity against polysaccharide encapsulated bacteria, a main group of causative pathogens for AOM, matures around this age.…”